USD 21.6
(-40.36%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 435.89 Million CHF | -41.78% |
2022 | 748.66 Million CHF | -4.54% |
2021 | 784.29 Million CHF | 5.03% |
2020 | 746.74 Million CHF | 27.39% |
2019 | 586.18 Million CHF | 107.19% |
2018 | 282.91 Million CHF | 74.06% |
2017 | 162.53 Million CHF | 3.05% |
2016 | 157.72 Million CHF | -1.82% |
2015 | 160.64 Million CHF | 6.55% |
2014 | 150.76 Million CHF | -0.64% |
2013 | 151.73 Million CHF | -15.72% |
2012 | 180.03 Million CHF | 187.26% |
2011 | 62.67 Million CHF | -5.14% |
2010 | 66.07 Million CHF | -15.54% |
2009 | 78.22 Million CHF | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 515.41 Million CHF | 18.24% |
2024 Q2 | 515.41 Million CHF | 0.0% |
2023 Q2 | 516.45 Million CHF | 0.0% |
2023 FY | 435.89 Million CHF | -41.78% |
2023 Q4 | 435.89 Million CHF | 0.0% |
2023 Q3 | 435.89 Million CHF | -15.6% |
2023 Q1 | 516.45 Million CHF | -31.02% |
2022 Q4 | 748.66 Million CHF | 0.0% |
2022 FY | 748.66 Million CHF | -4.54% |
2022 Q2 | 744.72 Million CHF | 0.0% |
2022 Q3 | 748.66 Million CHF | 0.53% |
2022 Q1 | 744.72 Million CHF | -5.04% |
2021 Q1 | 785.29 Million CHF | 5.16% |
2021 FY | 784.29 Million CHF | 5.03% |
2021 Q4 | 784.29 Million CHF | 0.0% |
2021 Q3 | 784.29 Million CHF | -0.13% |
2021 Q2 | 785.29 Million CHF | 0.0% |
2020 FY | 746.74 Million CHF | 27.39% |
2020 Q1 | 722.22 Million CHF | 23.21% |
2020 Q4 | 746.74 Million CHF | 0.0% |
2020 Q2 | 722.22 Million CHF | 0.0% |
2020 Q3 | 746.74 Million CHF | 3.39% |
2019 Q3 | 586.18 Million CHF | 58.35% |
2019 Q4 | 586.18 Million CHF | 0.0% |
2019 FY | 586.18 Million CHF | 107.19% |
2019 Q1 | 370.18 Million CHF | 30.85% |
2019 Q2 | 370.18 Million CHF | 0.0% |
2018 Q1 | 127.44 Million CHF | -21.59% |
2018 FY | 282.91 Million CHF | 74.06% |
2018 Q4 | 282.91 Million CHF | 0.0% |
2018 Q3 | 282.91 Million CHF | 63.83% |
2018 Q2 | 172.68 Million CHF | 35.5% |
2017 Q1 | 148.58 Million CHF | -5.8% |
2017 FY | 162.53 Million CHF | 3.05% |
2017 Q4 | 162.53 Million CHF | -2.99% |
2017 Q3 | 167.54 Million CHF | -2.16% |
2017 Q2 | 171.24 Million CHF | 15.26% |
2016 Q1 | - CHF | -100.0% |
2016 FY | 157.72 Million CHF | -1.82% |
2016 Q4 | 157.72 Million CHF | 0.0% |
2016 Q3 | 157.72 Million CHF | 67.25% |
2016 Q2 | 94.3 Million CHF | 0.0% |
2015 Q3 | 160.64 Million CHF | 80.68% |
2015 Q2 | 88.91 Million CHF | 0.0% |
2015 FY | 160.64 Million CHF | 6.55% |
2015 Q4 | 160.64 Million CHF | 0.0% |
2015 Q1 | 88.91 Million CHF | -41.03% |
2014 FY | 150.76 Million CHF | -0.64% |
2014 Q4 | 150.76 Million CHF | 0.0% |
2014 Q3 | 150.76 Million CHF | 76.62% |
2014 Q2 | 85.36 Million CHF | 0.0% |
2014 Q1 | 85.36 Million CHF | -43.74% |
2013 Q2 | 79.52 Million CHF | 0.0% |
2013 Q3 | 151.73 Million CHF | 90.8% |
2013 Q4 | 151.73 Million CHF | 0.0% |
2013 FY | 151.73 Million CHF | -15.72% |
2013 Q1 | 79.52 Million CHF | 0.0% |
2012 FY | 180.03 Million CHF | 187.26% |
2011 FY | 62.67 Million CHF | -5.14% |
2010 FY | 66.07 Million CHF | -15.54% |
2009 FY | 78.22 Million CHF | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alternative Energy Partners, Inc. | 3.15 Million USD | -13723.284% |
Allstar Health Brands, Inc. | 9.3 Million USD | -4585.158% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -722.854% |
Café Serendipity Holdings, Inc. | 1.31 Million USD | -32976.948% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | 543.26 Thousand USD | -80135.724% |
HealthWarehouse.com, Inc. | 7.21 Million USD | -5941.732% |
LIGAND PHARMACEUTICAL INC | 86.3 Million USD | -405.071% |
MedGen, Inc. | 43.63 USD | -999062471.625% |
Omni Health, Inc. | 1.94 Million USD | -22349.885% |
Oxford Investments Holdings Inc. | 1.01 Million USD | -42754.151% |
Pineapple, Inc. | 10.61 Million USD | -4005.615% |
ScripsAmerica, Inc. | 9.16 Million USD | -4654.902% |